Effects of ritonavir on the pharmacokinetics of doravirine in HIV-negative male volunteers
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2017
Price : $35 *
At a glance
- Drugs Doravirine (Primary) ; Ritonavir
- Indications HIV infections; HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections.
- 12 Nov 2013 New trial record
- 13 Sep 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.